October 31, 2019
We are delighted to be exhibiting at World Orphan Drug Congress, Barcelona in less than two weeks’ time. The conference agenda covers the strategic and commercial […]
May 17, 2021
Orphan Reach today confirmed that they have been acquired by Emmes, a global, full-service CRO dedicated to supporting the advancement of public health and biopharmaceutical innovation. […]
August 20, 2021
Emmes is excited to be attending the World Orphan Drug Congress USA 2021, from August 25th – 27th in Oxon Hill, MD USA The World Orphan […]
November 3, 2021
The new global Rare Disease center of Emmes expects accelerating growth from US and European biotechs. Emmes – a full service, global clinical research organization (CRO) […]